Craft

LabGenomics

Stock Price

₩3.6 K

2024-10-29

Market Capitalization

₩264.7 B

2024-10-29

Revenue

₩85.9 B

FY, 2024

LabGenomics Summary

Company Summary

Overview
LabGenomics ((주)랩지노믹스) is a healthcare company specializing in molecular diagnostics and functional genomics. It manufactures diagnostic products like DNA chips, polymerase chain reaction kits, point-of-care testing as well as medical devices. The company also provides molecular diagnostic tests, prenatal gene tests, hereditary disease analysis, next-generation sequencing (NGS), and other services.
Type
Public
Status
Active
Founded
2002
HQ
Seongnam-si, KR | view all locations
Website
https://labgenomics.co.kr/eng/
Cybersecurity rating
Sectors

Key People

  • Sunghyun Chin

    Sunghyun Chin, CEO

    Operating MetricsView all

    Medical Devices Integrated

    7

    Nov, 2023

    Product Categories

    4

    Nov, 2023

    Branches

    18

    Nov, 2023

    LocationsView all

    1 location detected

    • Seongnam-si, Gyeonggi-do HQ

      Korea (Republic of)

      700 Daewangpangyo-ro, Korea Bio Park Bldg. 6F-B, Bundang-gu

    LabGenomics Financials

    Summary Financials

    Revenue (Q3, 2025)
    ₩23.0B
    Gross profit (Q3, 2025)
    ₩11.4B
    Net income (Q3, 2025)
    (₩3.5B)
    Cash (Q3, 2025)
    ₩14.1B
    EBIT (Q3, 2025)
    (₩1.8B)
    Enterprise value
    $297.5B

    Footer menu